MSN Laboratories

Eli Lilly Issued Royalty Free Licenses for Baricitinib to Indian Pharma Companies

These three additional voluntary licensing agreements will ensure high-quality manufacturing and accessibility of baricitinib, improving local treatment options available to positively impact the lives of people who are currently battling Covid-19 in India.